The aim of this study was to investigate whether myocardial inflammation (MC) and endothelial activation are associated with clinically detectable endothelial dysfunction. BACKGROUND In patients with MC, immunohistologic evaluation of myocardial biopsies demonstrates a cellular infiltrate of lymphocytes in the myocardium and endothelial activation, as indicated by enhanced expression of human leukocyte antigen (HLA)-1, HLA-DR and intercellular adhesion molecule (ICAM)-1. This chronic inflammatory process may be associated with endothelial dysfunction.
Endothelial function plays a central roll in the development of vascular disease and represents a marker of prognostic relevance; endothelial dysfunction in coronary artery disease is associated with increased development of adverse coronary events (1, 2) . After heart transplantation, endothelial dysfunction anticipates the development of transplant vasculopathy and transplant failure (3) (4) (5) . Endothelial dysfunction has been observed in association with acute systemic inflammatory immune responses (6, 7) . It has been correlated with levels of C-reactive protein (8) . Furthermore, clinical studies have shown that endothelial function can be restored by suppression of inflammation in patients with systemic vasculitis (9) .
Immunohistologic evaluation of myocardial biopsies in patients with myocardial inflammation (MC) demonstrates a myocardial lymphocyte infiltrate and endothelial activation that can be detected by enhanced expression of cell adhesion molecules (CAMs) (10, 11) . Thus, the vessel wall is involved in the inflammatory process. Cell adhesion molecule expression is generally regulated by proinflammatory cytokines that can effect not only the local vasculature in the heart, but also, systemically, the peripheral vessels. A correlation between coronary and peripheral endothelial function has been demonstrated for other diseases (12) . The aim of the study presented here was to investigate whether the inflammatory process in the myocardium leads to a systemic deterioration of endothelial function. Furthermore, we aimed to elucidate if the severity of endothelial dysfunction in patients with MC correlates with the extent of endothelial activation, as detected by enhanced expression of human leukocyte antigen (HLA)-1, HLA-DR and intercellular adhesion molecule (ICAM)-1 in myocardial biopsies.
METHODS

Study population.
We included 65 consecutive patients with suspected MC, considering clinical symptoms and noninvasive testing as electrocardiogram (ECG), echocardiography or spiroergometry. When coronary artery disease was excluded by angiography, myocardial biopsies were obtained to establish a diagnosis. According to the findings in the myocardial biopsies, the patients were divided into a group with MC and a control group (Co). In 53 patients, MC was confirmed by immunohistology in myocardial biopsies; 12 patients had normal myocardial biopsies (Co). To minimize other confounding factors on endothelial dysfunction, patients with coronary artery disease (1,2), diabetes (13), more than one risk factor for arteriosclerosis (13) (14) (15) (16) , overt arteriosclerosis or other severe disease, like malignancy, autoimmune disorders, renal or hepatic failure or recent operations, were excluded from this study. As heart failure is known to affect endothelial function (17) (18) (19) (20) (21) (22) , we excluded patients with severely impaired left ventricular contractility (ejection fraction [EF] Ͻ35%). At the time of the study, the majority of patients was already on cardiovascular medication, which is known to influence endothelial function (23) (24) (25) . To exclude acute effects, all cardiovascular medication was ceased 12 h to 48 h before the study, depending on half-life. Patients were required to have sinus rhythm. Of 74 patients screened, 9 had exclusion criteria; 65 met the inclusion criteria.
Informed consent was obtained from all patients; the study protocol was approved by the local Ethics Committee of the Free University of Berlin. Myocardial biopsies. SAMPLE PREPARATION. Endomyocardial biopsies from the right ventricular septum were obtained by standard percutaneous transvenous femoral approach with a standard bioptome. For immunohistologic evaluation, the samples were prepared as published previously (11) (Fig. 1 ). As HLA-1, HLA-DR and ICAM-1 are constitutively expressed on endothelial cells, expression was enhanced, if immunoreactivity staining exceeded grade 1. The criteria for endothelial activation were met if, for two or more CAMs, immunoreactivity staining exceeded grade 1. Endothelial activation was graded according to the sum of endothelial expression of HLA-1, HLA-DR and ICAM-1: 3 to 4 normal, 5 to 7 moderate, 8 to 9 abundant. The myocardial biopsies were examined and analyzed by two independent blinded observers. Endothelial function. Endothelial function of the radial artery was assessed. By means of high-resolution ultrasound, diameter changes in response to reactive hyperemia (flowmediated vasodilation [FMD] ), as compared with glyceroltrinitrate (GTN) (endothelium-independent vasodilation [GTN-MD]), were detected, referring to the standard protocols (26, 27) . Accuracy and reproducibility have been documented (27) ; a low coefficient of variation for measurements of arterial diameter and a high correlation between consecutive control measurements have been demonstrated (26) . Flow-mediated vasodilation in response to reactive hyperemia (FMD) represents endothelium-dependent vasoreactivity, whereas vasodilation in response to GTN (GTN-MD) indicates smooth muscle cell function and is independent of endothelial function. Reactive hyperemia, induced by distal cuff occlusion and release, leads to a release of endothelium-dependent vasodilator substances mediated by shear stress, rather than ischemic metabolites. This endothelium-dependent vasodilation can be blocked by the nitric oxide synthase-inhibitor N(G)-monomethyl-Larginine (23, 22) . As the vessel diameter after reactive hyperemia is usually maximal after 45 s to 60 s, when flow velocity has already normalized, vasodilation is not due to physical requirements of enhanced flow (13, 26, 27) . TECHNICAL SETTINGS. The radial artery was examined by two-dimensional ultrasound images, with a 10-MHz linear array transducer and a standard 128XP/10c-system (Acuson, Mountain View, California). The transducer was positioned distal to the elbow to achieve a longitudinal picture of the radial artery. Transmit zone, depth and gain were set to optimize images of the lumen/arterial-wall interface; images were magnified by resolution box function; machine operating parameters were not changed during the study. Diameters were measured by means of a computerized edge detection program (Cardiovascular Imaging Software, Information-Integrity, Boston, Massachusetts); the images were acquired ECG-triggered at end-diastole throughout the study. Arterial flow velocity was measured by pulsed Doppler signal at a 70°angle to the vessel throughout the study. STUDY PROTOCOL. The subject lay at rest for at least 10 min before beginning the scan for endothelial function. A resting scan was recorded for 1 min. A pneumatic tourniquet, placed at the subject's wrist, was then inflated to a pressure of 300 mm Hg for 3 min. The release immediately induces increased blood flow in the subject's forearm for few seconds, which represents the stimulus for endotheliumdependent vasodilation. Vasodilation is generally maximal after 60 s, when flow has already normalized. The vessel was continuously scanned during the procedure, from baseline until 5 min after release of the cuff. A break of 10 min with the patient continuously supine was required before the scan for endothelium-independent vasodilation was started. After a resting scan, 400 g GTN was administered sublingually; the scan continued for 5 min after application. Maximal vasodilation generally occurs 4 min to 5 min after GTN administration. One experienced person performed all scans. The computer-assisted calculation of vessel diameters was conducted in a blinded fashion. The ECG was monitored continuously, and blood pressure was controlled throughout the study. All cardiovascular medication was ceased 12 h to 48 h before the study, depending on half-life. Quantitative data were correlated by use of the Spearman p rank-order analysis, calculating the coefficient of correlation r. Quantitative data were compared to qualitative data by use of the Kruskal-Wallis test on rank sums for independent samples, followed by a post-hoc multiple comparison procedure, if appropriate. To compare quantitative data of two groups, the Mann-Whitney U test was applied. Statistical significance was inferred at p Ͻ 0.01.
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RESULTS
Patients characteristics. Mean age of the 53 patients was 44 Ϯ 13 years; 21 were men, 32 women, mean left ventricular EF was 62 Ϯ 12% (Table 1 ). All patients were normotensive and had normal lipid levels. Five subjects were treated for hypertension, three for hypercholesterolemia, three were smokers. The patients were on standard cardiovascular medication. There were no significant differences in risk factors or medication between patients at different levels of endothelial activation (Table 1) . Mean age of the 12 control subjects was 45 Ϯ 13 years; six were men, six women, mean EF was 63 Ϯ 14% (Table  1 ). All patients were normotensive and had normal lipid levels. Two subjects were treated for hypertension, one for hypercholesterolemia, one was a smoker. Myocardial biopsies. Myocardial inflammation was confirmed by immunohistology in 53 subjects, applying the Table 1 .
Endothelial function. GENERAL CHARACTERISTICS.
Heart rate (74 Ϯ 8 beats/min) and blood pressure (systolic 121 Ϯ 9 mm Hg, diastolic 74 Ϯ 8 mm Hg) did not change significantly during measurements. Hemodynamic parameters were not significantly different between controls and patients with MC, nor between different levels of endothelial activation. Adequate reactive hyperemia as a stimulus for endothelium-dependent vasodilation was achieved in all subjects. Mean resting diameter of the radial artery was 2.47 Ϯ 0.47 mm; after reactive hyperemia the mean diameter increased to 2.60 Ϯ 0.48 mm and after GTN to 3.11 Ϯ 0.49 mm (Table 1) . FMD. Endothelial function, as determined by FMD of the radial artery, in patients with MC, was significantly impaired (FMD MC 4.28%), as compared with controls (FM-D Co 10.10%) (Fig. 2) (p Ͻ 0.001) . The severity of endothelial dysfunction in patients with MC correlates significantly with the extent of endothelial expression of HLA-1 (r ϭ Ϫ0.459, p ϭ 0.001), HLA-DR (r ϭ Ϫ0.287, p ϭ 0.037) and ICAM-1 (r ϭ Ϫ0.385, p ϭ 0.004) in myocardial biopsies (Fig. 3) . With increasing, enhanced expression of endothelial CAMs (sum score), endothelial function was progressively impaired, as measured by decreasing FMD (r ϭ Ϫ0.433, p ϭ 0.001) ( Data is expressed as mean Ϯ SD or absolute numbers (n). (Table 1) . Additionally, there was no significant correlation between EF and endothelial activation, as determined by endothelial expression of HLA-1 (r ϭ Ϫ0.062, p ϭ 0.660), HLA-DR (r ϭ Ϫ0.019, p ϭ 0.895), ICAM-1 (r ϭ Ϫ0.261, p ϭ 0.059) and the sum score of endothelial activation (r ϭ Ϫ0.174, p ϭ 0.212).
IMPACT OF AGE.
As all subjects in our study population were middle-aged, with only small variations, age had no impact on endothelial function. In patients with MC, there was no significant correlation between age and endothelial function (r ϭ Ϫ0.033, p ϭ 0.816) nor between age and endothelial activation (r ϭ Ϫ0.097, p ϭ 0.489). There were no significant differences in age comparing the different patient groups according to the levels of endothelial activation (Table 1) .
DISCUSSION
The results of this study demonstrate a systemic endothelial dysfunction in patients with immunohistologically confirmed MC. For the first time, endothelial activation in myocardial biopsies has been associated with systemic endothelial dysfunction in patients with MC. The severity of endothelial dysfunction correlates with the extent of endothelial expression of HLA-1, HLA-DR and ICAM-1. As other factors with impact on endothelial function have been minimized or excluded in this study, we interpret our findings towards a direct interaction between endothelial activation by inflammatory processes and endothelial dysfunction. Endothelium-independent vasoreactivity was not affected by MC or endothelial activation.
The impact of systemic inflammation (6, 7, 9) or circulating systemic inflammatory markers like C-reactive protein (8) and tumor necrosis factor-alpha (28, 29) on endothelial function has been demonstrated for other diseases. Cytokine-stimulated adhesion molecule expression has been observed in cultured human cardiac endothelial cells (30) . Similar mechanisms may play a role for endothelial dysfunction in patients with MC. Endothelial dysfunction of peripheral arteries in patients with MC could either be caused by systemic endothelial CAM expression due to generalized vascular inflammation or by circulating cytokines induced by the inflammatory process in the heart. A correlation between coronary and peripheral endothelial function has been demonstrated for arteriosclerosis (12) . Our recent research is focused on investigating these relations in patients with MC.
Consistent with the literature (17-21,22), we found a correlation between endothelial dysfunction and left ventricular dysfunction. As left ventricular function was equally mildly impaired in all groups with different levels of endothelial activation, this did not alter our results with respect to the effect of endothelial activation and inflammation on endothelial function. Endothelial activation and left ventricular function, both, independently from each other, predict endothelial dysfunction in patients with MC.
To interpret our findings within a clinical context, it is important to understand that endothelial dysfunction potentially represents a marker of prognostic relevance (1, 3, 4) . For patients with ischemic heart disease and after transplantation, this has already been demonstrated (1-5); for patients with MC, it remains to be verified.
